2024 annual financial data
TScan Therapeutics 2024 Financial results
Direct answer
Revenue was 2.82M USD.
Operating income was -134.82M USD and net income was -127.5M USD.
Operating cash flow was -110.82M USD.
Get free TScan Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2.82M USD
- Operating income
- -134.82M USD
- Net income
- -127.5M USD
- Operating cash flow
- -110.82M USD
Explore related company data
View all 2024 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all TScan Therapeutics financial years